本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

11.48
+0.29002.59%
盘前11.990.5138+4.48%08:31 EDT
成交量:161.19万
成交额:1,854.98万
市值:17.44亿
市盈率:-11.98
高:11.81
开:11.25
低:11.20
收:11.19
数据加载中...
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/28

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/09

重要事件披露

Form 8-K - Current report
2024/04/05

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report